Noninvasive and Quantitative Assessment of <i>In Vivo</i> Fetomaternal Interface Angiogenesis Using RGD-Based Fluorescence

<table>Protocol of gravid mouse treatment. Angiolone-Alexa-Fluor 700 was injected one day before imaging at days 6.5 and 11.5 dpc. Mice were analyzed at days 7.5 and 1.25 dpc, respectively.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Noninvasive and Quantitative Assessment of <i>In Vivo</i> Fetomaternal Interface Angiogenesis Using RGD-Based Fluorescence 

BioMed Research International

Noninvasive and Quantitative Assessment of In Vivo Fetomaternal Interface Angiogenesis Using RGD-Based Fluorescence

Figure 1